2,803 results on '"Nishio, M"'
Search Results
52. The web‐based accumulated rainfall amount monitoring system by X‐band MP radar
53. Strategy to develop efficient grid system for flow analysis around two-dimensional bluff bodies
54. First-line nivolumab + ipilimumab in advanced NSCLC : CheckMate 227 subpopulation analyses in Asian patients
55. Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with GenexusTM integrated sequencer
56. Efficacy and safety of capmatinib plus spartalizumab in treatment-naive patients with advanced NSCLC harboring MET exon 14 skipping mutation
57. P489 Double-dose infliximab therapy in Crohnʼs disease: appropriate time to evaluate the efficacy, long-term efficacy and safety
58. P337 Efficacy of intravenous cyclosporine in fulminant steroid-refractory ulcerative colitis with massive bleeding: a retrospective, observational study
59. P133 A novel candidate pathway for development of neoplasms with serrated morphology in patients with ulcerative colitis
60. Cost-effectiveness of cognitive remediation and supported employment for people with mental illness: a randomized controlled trial
61. Visualization Study of Heat Transport Mechanism in Supercritical Nitrogen
62. Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA
63. The CH/π hydrogen bond: Implication in chemistry
64. Effects of substrate temperature upon the properties of ZnMgTe layer grown by MOVPE
65. Age-related changes in gene expression of the growth hormone secretagogue and growth hormone-releasing hormone receptors in Holstein-Friesian cattle
66. 13P Durvalumab + chemotherapy in patients (pts) with advanced EGFR mutation-positive (EGFRm) NSCLC whose disease progressed on first-line (1L) osimertinib: An ORCHARD study interim analysis
67. Efficacy of Brigatinib in Patients With Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Who Progressed on Alectinib or Ceritinib: ALTA-2 Study
68. Numerical Analysis of Heat Transport Mechanism in Nitrogen Near the Critical Point
69. Micro-/Nano-structuring based on self-assembly of particles to improve surface functionality in biomedical applications
70. Effect of VI/II ratio upon photoluminescence and electrical properties of phosphorus-doped ZnTe films grown by metalorganic vapor phase epitaxy
71. P276 Prevalence, clinicopathological, and biological characteristics of serrated polyps in patients with ulcerative colitis
72. P291 Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study
73. Src family kinase inhibitor PP1 improves motor function by reducing edema after spinal cord contusion in rats
74. 122MO Nivolumab (NIVO) + ipilimumab (IPI) as first-line (1L) treatment (tx) for patients (pts) with advanced NSCLC (aNSCLC) and baseline (BL) brain metastases (mets): Intracranial and systemic outcomes from CheckMate 227 Part 1
75. Thermal and Nonthermal Flare Emission Observed with the Nobeyama Radio Heliograph
76. Vero/BC-F: an efficient packaging cell line stably expressing F protein to generate single round-infectious human parainfluenza virus type 2 vector
77. Whole body and intracranial efficacy of ceritinib in patients (pts) with crizotinib (CRZ) pretreated, ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and baseline brain metastases (BM): Results from ASCEND-1 and ASCEND-2 trials: 141PD
78. Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration
79. MO1-1 6y update of 1L nivolumab + ipilimumab (N+I) in metastatic (m) NSCLC, including in Japanese pts, from CheckMate 227.
80. Microwave Observations of the Sun During the 22nd Solar Activity Cycle — 17 GHz Radio Heliograph
81. Photonic Wavelength-Division Switching Network Using a Parallel λ-Switch
82. Application of Optical FSK Signals to Wavelength-Division Switching Systems
83. P53.04 Local Therapies vs. Specific TKIs as the Initial Treatment for Oligo-Recurrent Lung Adenocarcinoma With Driver Mutations
84. P59.11 Real-World Data of NGS Diagnostic Biomarker Testing for Lung Cancer Patients in Japan
85. FP04.01 Nivolumab 480 mg Every 4 Weeks as De Novo Second-line Treatment for Advanced Non-Small Cell Lung Cancer: CheckMate 907
86. MA07.02 Evaluating Circulating Tumor DNA to Predict Overall Survival Risk in Non-Squamous Non-Small Cell Lung Cancer in IMpower150
87. 1209P RELAY, ramucirumab plus erlotinib (RAM+ERL) in untreated metastatic EGFR-mutant NSCLC (EGFR+NSCLC): Association between TP53 status and clinical outcome
88. A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)
89. Genomic best linear unbiased prediction method reflecting the degree of linkage disequilibrium
90. A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial
91. Biphasic modulation by mGlu5 receptors of TRPV1-mediated intracellular calcium elevation in sensory neurons contributes to heat sensitivity
92. Capmatinib in Patients with METex14-Mutated Non-Small Cell Lung Cancer: GEOMETRY Mono-1 Asian Subgroup Analysis
93. P415 Paradoxical onset of Takayasu’s arteritis in patients with inflammatory bowel disease treated with anti-tumour necrosis factor-α agents
94. First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1
95. Phase 2 GEOMETRY Mono-1 Study: Capmatinib in Patients with METex14-mutated Advanced Non-Small Cell Lung Cancer who Received Prior Immunotherapy
96. An Extremely Rare Malignant Glomus Tumor of the Breast: A Case Report and Review of the Literature
97. Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells
98. Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD
99. LBA2 ALINA: Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC)
100. Accounting for numbers of expressions of specific genotypes using a modified gene-flow method
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.